ABEO Price / Book | ABEONA THERAPEUTICS INC.

ABEONA THERAPEUTICS INC. (ABEO) Price / Book

2026-09-03: Price/Book Ratio 2.65.
2026-06-30: Price/Book Ratio 2.76.
2026-03-31: Price/Book Ratio 1.76.
2025-12-31: Price/Book Ratio 1.82.

Historical market capitalization divided by filed shareholder equity.

Available history: 2015-03-31 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	2.65
2026-06-30	2.76
2026-03-31	1.76
2025-12-31	1.82
2025-09-30	1.62
2025-06-30	1.78
2025-03-31	5.63
2024-12-31	5.77
2024-09-30	5.99
2024-06-30	2.41
2023-12-31	8.96
2023-09-30	4.72
2023-06-30	9.26
2023-03-31	2.7
2022-12-31	2.04
2022-09-30	1.88
2022-06-30	2.2
2022-03-31	55.55
2021-12-31	1.18
2021-09-30	35.77
2021-06-30	46.96
2021-03-31	49.31
2020-12-31	36.79
2020-09-30	18.72
2020-06-30	51.13
2020-03-31	33.16
2019-12-31	38.31
2019-09-30	30.03
2019-06-30	54.92
2019-03-31	74.9
2018-12-31	63.84
2018-09-30	102.11
2018-06-30	117.59
2018-03-31	99.81
2018-01-02	3,200.3
2018-01-01	105.34
2017-12-31	109.23
2017-09-30	191.06
2017-06-30	72.31
2017-03-31	52.58
2016-12-31	49.25
2016-09-30	79.26
2016-06-30	31.47
2016-03-31	31.91
2015-12-31	40.6
2015-09-30	45.3
2015-06-30	51.21
2015-03-31	496.71

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
GT Biopharma, Inc. (GTBP)	United States	$0.309B	-4.58
Prelude Therapeutics Inc (PRLD)	United States	$0.318B	-7.01
Evommune, Inc. (EVMN)	United States	$0.320B	-5.10
BridgeBio Oncology Therapeutics, Inc. (BBOT)	United States	$0.320B	-3.35
Vanda Pharmaceuticals Inc. (VNDA)	United States	$0.302B	-1.35
STANDARD BIOTOOLS INC. (LAB)	United States	$0.297B	3.80
ROCKET PHARMACEUTICALS, INC. (RCKT)	United States	$0.296B	-21.78
BioAge Labs, Inc. (BIOA)	United States	$0.333B	-11.88
Fulcrum Therapeutics, Inc. (FULC)	United States	$0.289B	-3.28
Contineum Therapeutics, Inc. (CTNM)	United States	$0.289B	-4.40